These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36685857)

  • 21. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
    Chen Q; Tang P; Huang H; Qiu X
    Front Immunol; 2022; 13():934124. PubMed ID: 35958575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel oxidative stress- and ferroptosis-related gene prognostic signature for distinguishing cold and hot tumors in colorectal cancer.
    Wang X; Xu Y; Dai L; Yu Z; Wang M; Chan S; Sun R; Han Q; Chen J; Zuo X; Wang Z; Hu X; Yang Y; Zhao H; Hu K; Zhang H; Chen W
    Front Immunol; 2022; 13():1043738. PubMed ID: 36389694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
    Shen KY; Chen BY; Gao WC
    Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
    Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
    Front Immunol; 2022; 13():994874. PubMed ID: 36330513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
    Li X; Zhang Q; Zhao L; Jiang L; Qi A; Wei Q; Song X; Wang L; Zhang L; Zhao Y; Lv X; Wei M; Zhao L
    J Cancer; 2020; 11(8):2139-2149. PubMed ID: 32127941
    [No Abstract]   [Full Text] [Related]  

  • 29. A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients.
    Zou YF; Rong YM; Tan YX; Xiao J; Yu ZL; Chen YF; Ke J; Li CH; Chen X; Wu XJ; Lan P; Lin XT; Gao F
    Cancer Cell Int; 2019; 19():243. PubMed ID: 31572060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer.
    Feng J; Wei Q; Yang M; Wang X; Liu B; Li J
    Ann Transl Med; 2021 May; 9(9):747. PubMed ID: 34268360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysis.
    Wang L; Liu D; Liu S; Liao T; Jiao Y; Jiang X; Wang Y; Chen Y; Ma H; Cai H
    Transl Oncol; 2022 Jul; 21():101435. PubMed ID: 35483170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Circular RNA-Related Competing Endogenous RNA Identifies the Immune-Related Risk Signature for Colorectal Cancer.
    Song W; Ren J; Wang C; Ge Y; Fu T
    Front Genet; 2020; 11():505. PubMed ID: 32582276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
    Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
    Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
    Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
    Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics.
    Gong B; Kao Y; Zhang C; Sun F; Gong Z; Chen J
    Mediators Inflamm; 2020; 2020():5934821. PubMed ID: 32351322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis.
    Rahman MR; Islam T; Gov E; Turanli B; Gulfidan G; Shahjaman M; Banu NA; Mollah MNH; Arga KY; Moni MA
    Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30658502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients.
    Li J; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Deng Y
    Cancer Manag Res; 2020; 12():3301-3310. PubMed ID: 32494194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated transcriptional profiling and genomic analyses reveal RPN2 and HMGB1 as promising biomarkers in colorectal cancer.
    Zhang J; Yan B; Späth SS; Qun H; Cornelius S; Guan D; Shao J; Hagiwara K; Van Waes C; Chen Z; Su X; Bi Y
    Cell Biosci; 2015; 5():53. PubMed ID: 26388988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.